Cellular Medicine in Viral Diseases

The body’s basic protection against viral invaders is secured by the white blood cells (“police cells”). If an infection occurs in the body, monocytes travel to the source of infection. To reach the site that has been invaded by a virus, these infection-fighting cells must be able to move through the connective tissue. To do this, monocytes secrete collagen-digesting enzymes that temporarily dissolve the surrounding connective tissue.

This same collagen-dissolving mechanism plays an especially important role in infectious diseases. Without the disruption of the surrounding connective tissue, the agents that cause diseases (viruses, bacteria) cannot invade the body and spread. A virus consists only of software (genetic information). As soon as the virus has invaded the host cell, it incorporates its genetic information into the nucleus of the host.

The following two steps occur in the infection process:

Step 1: Multiplication of the Virus
The metabolic production system of the host cell receives an order to multiply the virus particles. After multiple reproduction cycles, virus particles are released by the host cell into the surrounding area where the newly made viruses can invade new cells.

Step 2: Mass production of Collagen-Dissolving Enzymes
The virus also orders the host cell to produce collagen-digesting enzymes. The host cell excretes these enzymes, which start to dissolve the surrounding tissue. The infection then can easily spread to other parts of the body. The more a virus is capable of using the metabolism of a host cell for these two purposes, the faster a virus infection will spread and the sicker a patient will feel.

In infectious diseases caused by viruses, such as flu, herpes, and AIDS, lysine can stop or slow down the aggressive spread of an infection with . Supplementation with vitamin C and other nutrients can bring additional health benefits.

.........................................................................................

Read the results of a viral disease clinical study.